PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia and internationally. The company operates through Biopharma, Consumer Health, and Others segments. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines. The company also engages in research, development, production, and distribution of pharmaceutical and biological prescription medicines to treat colorectal cancer, head and neck cancer, multiple sclerosis, infertility, growth hormone disorders, and diabetes, as well as thyroid disorders, such as hypothyroidism. In addition, it is involved in the office/property leasing and management activities. The company was formerly known as PT Merck Indonesia Tbk and changed its name to PT Merck Tbk in June 2002. The company was founded in 1970 and is based in Jakarta Timur, Indonesia. PT Merck Tbk operates as a subsidiary of Merck Holding GmbH.
Frequently asked questions
What sector does Merck Tbk (MERK) operate in?
Merck Tbk belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Merck Tbk (MERK) current stock price?
As of the latest data, Merck Tbk stock price is IDR 3,910, with a previous close of IDR 3,910.
What is Merck Tbk (MERK) current market capitalization?
Merck Tbk market cap is approximately 1.75 trillion.
What is Merck Tbk (MERK) Earnings Per Share (EPS)?
The trailing EPS is IDR 743.
What is Merck Tbk (MERK) Price-to-Earnings (P/E) ratio?
Merck Tbk current P/E ratio is 5.26.
What is Merck Tbk (MERK) EBITDA?
Merck Tbk EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 62.39 billion.
Does Merck Tbk (MERK) pay dividends?
Yes. Merck Tbk pays annual dividends with an annualized yield of 7.03% and an estimated annual payout of IDR 275 per share.
When is the next ex-dividend date for Merck Tbk (MERK)?
The next ex-dividend date is scheduled for June 08, 2027.
What is Merck Tbk (MERK) beta (volatility) score?
Merck Tbk has a beta of 0.172, indicating lower volatility than the overall market.
